IsoRay, Inc.
(NYSE Amex Equities : ISR)

( )
ISR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc -8.43%4.781.6%$98.53m
PRGOPerrigo Co. Plc 3.48%44.296.8%$81.13m
JAZZJazz Pharmaceuticals Plc -0.77%98.762.3%$79.69m
VRXValeant Pharmaceuticals International, Inc. -2.14%13.2914.1%$78.20m
UTHRUnited Therapeutics Corp. -0.85%92.7414.3%$69.65m
CTLTCatalent, Inc. -1.99%48.952.2%$68.14m
HZNPHorizon Therapeutics Plc -1.51%31.376.5%$67.20m
ICLRICON plc 0.82%130.864.2%$64.76m
AXSMAxsome Therapeutics, Inc. -1.15%55.021.9%$63.80m
GWPHGW Pharmaceuticals Plc -3.22%81.806.2%$51.36m
ICPTIntercept Pharmaceuticals, Inc. -2.38%58.7516.8%$38.37m
SAGESAGE Therapeutics, Inc. -2.99%25.958.6%$34.16m
PBHPrestige Consumer Healthcare, Inc. -1.39%37.554.0%$33.18m
PCRXPacira Biosciences, Inc. -5.46%30.8010.4%$28.72m
MYOKMyoKardia, Inc. -0.07%46.372.1%$25.67m

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.